© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
881195 |
As an accredited 2-Bromo-4-(Tert-Butyl)Pyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 2-Bromo-4-(Tert-Butyl)Pyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In research labs and production facilities where new therapies, advanced materials, and specialty chemicals are born, there’s always a search for building blocks with unique tricks up their sleeve. A name that pops up among those who know their way around a fume hood is 2-Bromo-4-(tert-butyl)pyridine. This compound, with the formula C9H12BrN and CAS number 81565-18-6, tends to attract attention from synthetic chemists who prefer precise, reliable tools. The story behind this molecule is less about commercial bells and whistles and more about what it can really do at the bench—especially in reactions where other aryl bromides fall short.
Let’s get the basics out of the way. Chemists recognize 2-bromo-4-(tert-butyl)pyridine by its signature scaffold: a pyridine ring—think of it as a cousin to benzene, but one of the carbons is replaced with a nitrogen—bearing a bromine atom at the 2-position and a tert-butyl group at position 4. That tert-butyl group isn’t just for show; it offers serious steric protection and influences the molecule's reactivity, solubility, and even physical handling. Bromine at the 2-position acts as a flag for coupling reactions, especially those using palladium catalysis. The combination of electronic effects from the nitrogen and the tert-butyl group gives this molecule properties that stand apart from standard bromo-pyridines.
Most days for a synthetic chemist follow a pattern—choose a route, gather reactants, set up the flask, and try to outsmart the periodic table. The moment the decision lands on a substituted pyridine, the reasons are rarely arbitrary. Labs chasing after novel ligands, heteroaromatic pharmaceuticals, or exquisite organometallic probes know the nuances involved. Compared to plain 2-bromopyridine, adding a bulky tert-butyl group gives you better control over selectivity. In coupling and substitution reactions, the tert-butyl acts as a block, steering the course and minimizing unwanted side-products. This really comes into play in Suzuki, Stille, and Buchwald-Hartwig methods, where regioselectivity and yield matter—not only in milligram discovery chemistry but also as scale climbs for pilot batches.
If you've been on the hunt for improved yields and cleaner separations in heterocyclic chemistry, you'll understand the frustration when an unprotected position undergoes unwanted reactions. The tert-butyl group safeguards against many of these headaches. A classic example is during cross-coupling; the tert-butyl blocks access to the 4-position, eliminating reactivity at this location and handing more of the control to the chemist.
Competition among aryl halides is fierce, and chemists can easily reach for dozens of options. The specific pattern of bromine at C2 and tert-butyl at C4 isn’t ubiquitous in stockrooms for ornamental value. The structure delivers certain payoffs that can make or break a synthesis plan:
Standard bromo-pyridines tend to be reactive across more positions, resulting in less controlled reactions and often a scramble to chromatograph away pesky byproducts. The tert-butyl block means a cleaner reaction flask, a smaller purification headache, and a better yield after hours of stirring and TLC-checking. In my time running palladium-catalyzed couplings, the difference between a clean NMR and a mess came down to the right choice of substituents, and this molecule offered a level of predictability that made planning much less stressful.
This isn’t the sort of chemical you’ll find gathering dust on a shelf. Drug discovery teams scan for building blocks that offer quick paths to new chemical space. If you follow the patent trail on kinase inhibitors or CNS ligands, there’s a strong chance a substituted pyridine rings at the center. The tert-butyl group is prized by medicinal chemists for its ability to boost bioavailability, improve metabolic stability, and help molecules slip past certain metabolic roadblocks.
Beyond pharma, material scientists and researchers developing new catalysts lean on this molecule for its well-defined framework. In ligand design, small changes in structure yield massive changes in metal coordination and reactivity. Swapping a methyl or isopropyl for a tert-butyl can drastically alter the binding pocket’s size or hydrophobicity, leading to big swings in catalytic performance.
I remember pushing through a round of catalyst optimization—one run with an unadorned bromo-pyridine, the other with the tert-butyl in place—and watching the conversion shoot up from 50% to nearly quantitative. That single tweak simplified the process downstream, reduced byproducts, and trimmed hours off the workup. It’s proof that small changes at the molecular level often ripple out to big savings in time and cost.
Looking across the line of available pyridine derivatives, the big question is always: why not stick with standard substituents, like methyl, ethyl, or even no alkyl group? Methyl groups provide some stability, sure, but they won’t impart the same spatial blocking. Ethyls offer a touch more bulk than methyl, but tert-butyl plants a solid wall in the way—enough to block competitive substitution, resist metabolic attack (which increases half-life in biological settings), and nudge the compound’s melting point, volatility, and solubility.
Similar patterns show up with halides. Bromo sits in a sweet spot for many chemists: more reactive than chloro, safer and less toxic than iodo. That reactivity is supercharged by the electron-deficient nature of the pyridine ring, but it’s the additional steric hindrance at position 4 that pulls this molecule out from the crowd. You won’t see the same selectivity, control, or efficiency from simpler analogues. Those extra tenths of a gram and missing hours spent on column chromatography quickly add up in an industry where speed to result equals money.
Even reliable compounds can bring their own quirks. The tert-butyl group, while great for selectivity, can impact crystallinity or present handling issues at low temperatures. Still, compared to sticky, resinous intermediates or stinky amines, 2-bromo-4-(tert-butyl)pyridine comes across as approachable. Proper storage in a dry, cool cabinet and careful measurement at the bench are routine; most reported melting points land in a reasonable range, and the compound’s stability in organic solvents keeps it viable even across long syntheses.
Another consideration is waste. Brominated byproducts demand careful disposal protocols. Labs with robust waste handling systems can offset this, but keeping processes efficient cuts down on the amount of hazardous waste generated in the first place. I’ve seen pharma teams run late-stage diversification with dozens of aryl halides, but the sharpest chemists work backward from the waste stream, choosing molecules like this for their blend of performance and manageability.
Bench chemistry isn’t the whole story. Getting from test tube to pilot reactor means ramping up material production, and that’s where material properties matter. The tert-butyl group’s impact on melting point and solubility makes it suitable for solution-phase and solid-phase work, and the clean, sharp coupling reactions translate well into larger vessels. The fewer the byproducts, the less spent on downstream separation. In scale-up, reactions with 2-bromo-4-(tert-butyl)pyridine often run at lower temperatures and shorter reaction times, especially in palladium- or nickel-catalyzed couplings.
Bulk purchasers in fine chemicals, pharma, and agrochemical production favor routes that offer this kind of operational wiggle room. Beyond yield, it’s the reduction in batch-to-batch variability and regulatory paperwork associated with impurities that wins over process engineers. Energy savings from leaner, shorter reactions aren’t just good for the bottom line—they support green chemistry initiatives and can help companies trim their environmental footprint, a topic that’s only growing in significance.
To outsiders, the difference between 2-bromo-4-(tert-butyl)pyridine and another bromoarene may seem trivial—a matter of a few atoms. But to researchers guiding precious time and dollars toward a target molecule, that difference is everything. Synthetic chemistry is about controlling outcomes, minimizing surprises, and reducing the number of steps from raw material to finished product. Molecules like this don’t just make experiments smoother; they open doors to space-efficient syntheses, less wasteful reactions, and easier routes to once-tricky analogues. With new regulatory scrutiny on pharmaceutical process efficiency and environmental impact, incremental improvements compound quickly.
Every time a chemical leaves a supplier and finds its way onto a research bench, the promise is consistency. You want purity above 98% because any ambiguities in NMR, LCMS, or GC can derail days of work. With 2-bromo-4-(tert-butyl)pyridine, experienced suppliers maintain tight analytical controls, often verifying identity and strength using proton and carbon NMR, HPLC, and mass spec. The presence of the tert-butyl group in the spectra gives a distinct singlet, simplifying quality checks.
Having been on both sides—ordering standard reagents for routine coupling and vetting specialty intermediates for grant-driven research—I know the anxiety that can set in if a key building block is out of stock or varies in purity. Projects get re-prioritized, timelines slip, or worse, early results get invalidated from batch-to-batch inconsistency. Reliable access to high-purity batches can be the difference between a publication, a patent, or simply a lost month chasing ghosts in spectra.
Analytical labs prioritize traceability and documentation. They look for detailed certificates of analysis, spectral data, and information on any observed impurities. This transparency forms a backbone of trust across every stage, from academic research to regulated production. It isn’t just a box-checking exercise—chemists genuinely rely on it to troubleshoot, confirm identity, and report with accuracy.
Looking across literature and patent filings, the applications of 2-bromo-4-(tert-butyl)pyridine span a wide arc—from antihistamine and CNS drug candidates to cross-coupling partners in OLED materials and advanced polymers. Its electronic and steric profile suits molecules that must resist breakdown in biological tissues or operate under heat and electric fields. There’s ongoing interest in using such intermediates in combinatorial chemistry, where high-throughput screening demands quick, effective assembly of diverse scaffolds.
Many biotech startups and incubator labs streamline their synthetic routes by picking privileged scaffolds—those that deliver the most chemical space quickly. Substituted pyridines top the list, and this specific bromo-tert-butyl combo pops up again and again, cited in breakthrough medicinal chemistry campaigns. Teams lead with it not only for functional efficiency but for the breadth it brings to analog development and IP portfolios.
Safety and environmental consciousness play an increasing role in chemical process choice—gone are the days where yield alone shut down analysis of broader impacts. For all the positives of 2-bromo-4-(tert-butyl)pyridine, the industry must remember the proper handling of brominated intermediates, use of gloves, and ventilation, along with compliance to waste disposal guidelines.
Sourcing high-purity grades delivers on safety not only for those in the lab but for those responsible for downstream applications and ultimate end-users—whether those are patients, consumers, or the broader environment. Regulatory and consumer demands push suppliers to improve transparency, invest in cleaner production methods, and offer detailed data on each batch.
Charting the trajectory of substituted pyridines and aryl halides, future advances seem anchored in making these versatile blocks even more accessible, affordable, and sustainable. Ongoing research into green synthetic approaches may allow for brominations that avoid hazardous reagents. Scale-up innovations could further cut waste and improve atom economy. Increasingly, digital inventories and global supply chain improvements offer the prospect of faster, more reliable access to niche reagents, even in remote labs or tight timelines.
R&D teams chase new analogues that tap into the unique dance between electronics and sterics—traits 2-bromo-4-(tert-butyl)pyridine delivers in spades. As medicinal chemistry, materials science, and catalysis intersect, demand for such functionalized building blocks will likely continue to rise.
No tool is perfect, and improvements always remain on the horizon. Scaling up access beyond high-end suppliers by encouraging better distribution networks could support more research teams in emerging markets or startup environments. Collaboration between academic labs, fine chemical manufacturers, and contract research organizations could further standardize quality benchmarks, making it easier for newcomers to navigate the crowded world of aryl halides.
Environmental impact sits at the forefront of process innovation. Alternative coupling methods that minimize the use of precious metals and enable milder reaction conditions could help bring down the risk profile associated with aryl bromides. Better-developed recycling streams for brominated waste—as well as robust documentation on lifecycle impacts—may come to play a vital role, especially when answering to regulatory bodies or sustainability-conscious investors.
With each new reaction and project, chemists weigh dozens of options before picking a building block for the work ahead. Personal experience, literature, and supplier transparency all come into play. 2-bromo-4-(tert-butyl)pyridine stands out for its ability to deliver controlled, predictable transformations in the sandwich of innovation between medicinal chemistry, material science, and process development. It has proven, time and again, that sometimes the secret to breakthrough isn’t just the most exotic molecule—but the right substitution pattern, a careful choice, and an eye for what really works at the bench, the pilot plant, and beyond.
